{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:03:20Z","timestamp":1789592600097,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2015.00141","type":"journal-article","created":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T08:34:28Z","timestamp":1441960468000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Pituitary Adenoma and the Chemokine Network: A Systemic View"],"prefix":"10.3389","volume":"6","author":[{"given":"Fabio","family":"Grizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Monica","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina","family":"Qehajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Stifter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Chiriva-Internati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Ieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrendo.2014.64","article-title":"Aggressive pituitary adenomas \u2013 diagnosis and emerging treatments","volume":"10","author":"Di Ieva","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J Neurooncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"R121","DOI":"10.1530\/EJE-13-1031","article-title":"Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies","volume":"170","author":"Raverot","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12022-014-9322-y","article-title":"In search of a prognostic classification of endocrine pituitary tumors","volume":"25","author":"Trouillas","year":"2014","journal-title":"Endocr Pathol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3502::AID-CNCR183.0.CO;2-2","article-title":"The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme","volume":"78","author":"Kovacs","year":"1996","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1172\/JCI20401","article-title":"Mechanisms for pituitary tumorigenesis: the plastic pituitary","volume":"112","author":"Melmed","year":"2003","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","article-title":"Pathogenesis of pituitary tumors","volume":"7","author":"Melmed","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ecl.2014.11.004","article-title":"Pituitary tumors","volume":"44","author":"Melmed","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11102-012-0448-y","article-title":"Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management","volume":"16","author":"Zemmoura","year":"2013","journal-title":"Pituitary"},{"key":"B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fendo.2015.00097","article-title":"Progress in the diagnosis and classification of pituitary adenomas","volume":"6","author":"Syro","year":"2015","journal-title":"Front Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3803\/EnM.2013.28.4.245","article-title":"The molecular pathogenesis of pituitary adenomas: an update","volume":"28","author":"Jiang","year":"2013","journal-title":"Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1055\/s-2005-870153","article-title":"Epigenetic mechanisms of tumorigenesis","volume":"37","author":"Farrell","year":"2005","journal-title":"Horm Metab Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/BF03346759","article-title":"MicroRNAs: suggested role in pituitary adenoma pathogenesis","volume":"36","author":"Gadelha","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12022-011-9167-6","article-title":"MicroRNAs in the human pituitary","volume":"22","author":"Sivapragasam","year":"2011","journal-title":"Endocr Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0648-3","article-title":"MicroRNA involvement in a metastatic non-functioning pituitary carcinoma","author":"Wei","year":"2015","journal-title":"Pituitary"},{"key":"B16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Di Ieva","year":"2014","journal-title":"Neurosurgery"},{"key":"B17","doi-asserted-by":"publisher","first-page":"435171","DOI":"10.1155\/2014\/435171","article-title":"MicroRNAs in human pituitary adenomas","volume":"2014","author":"Li","year":"2014","journal-title":"Int J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000079039","article-title":"Growth factors and cytokines: function and molecular regulation in pituitary adenomas","volume":"32","author":"Renner","year":"2004","journal-title":"Front Horm Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11060-010-0152-6","article-title":"The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells","volume":"100","author":"Yoshida","year":"2010","journal-title":"J Neurooncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charo","year":"2006","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bph.12665","article-title":"International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacol Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1471-4906(01)01941-X","article-title":"Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines","volume":"22","author":"Mantovani","year":"2001","journal-title":"Trends Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nri1964","article-title":"Tuning inflammation and immunity by chemokine sequestration: decoys and more","volume":"6","author":"Mantovani","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev.pharmtox.48.121806.154841","article-title":"Chemokines and their receptors: drug targets in immunity and inflammation","volume":"48","author":"Viola","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fncel.2014.00154","article-title":"Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers","volume":"8","author":"Williams","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.brainresrev.2004.07.021","article-title":"Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases","volume":"48","author":"Cartier","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1677\/JME-06-0035","article-title":"Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation","volume":"38","author":"Callewaere","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"B28","first-page":"8342","article-title":"Neuroinflammation in Alzheimer\u2019s disease: chemokines produced by astrocytes and chemokine receptors","volume":"7","author":"Liu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fncel.2014.00065","article-title":"CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems","volume":"8","author":"Guyon","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pneurobio.2013.02.001","article-title":"Current status of chemokines in the adult CNS","volume":"104","author":"Reaux-Le Goazigo","year":"2013","journal-title":"Prog Neurobiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/dneu.22041","article-title":"Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives","volume":"72","author":"Zhu","year":"2012","journal-title":"Dev Neurobiol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1196\/annals.1378.037","article-title":"CXC receptor and chemokine expression in human meningioma: SDF1\/CXCR4 signaling activates ERK1\/2 and stimulates meningioma cell proliferation","volume":"1090","author":"Barbieri","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1215\/15228517-2006-023","article-title":"CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro","volume":"9","author":"Bajetto","year":"2007","journal-title":"Neuro Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cytogfr.2012.08.007","article-title":"Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12","volume":"24","author":"Singh","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.4161\/cbt.8.17.9202","article-title":"CXCL12, CXCR4 and CXCR7 expression in brain metastases","volume":"8","author":"Salmaggi","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1592\/phco.30.5.485","article-title":"Plerixafor: a peripheral blood stem cell mobilizer","volume":"30","author":"Kessans","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10014-010-0013-1","article-title":"CXCL12\/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target","volume":"28","author":"Terasaki","year":"2011","journal-title":"Brain Tumor Pathol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"13513","DOI":"10.1073\/pnas.2235846100","article-title":"A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors","volume":"100","author":"Rubin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1210\/en.137.10.4503","article-title":"Endotoxin activates a chemokinergic neuronal pathway in the hypothalamo-pituitary system","volume":"137","author":"Sakamoto","year":"1996","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5858\/2000-124-0520-EOTCRC","article-title":"Expression of the chemokine receptor CXCR2 in normal and neoplastic neuroendocrine cells","volume":"124","author":"Tecimer","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00441-014-1864-2","article-title":"Expression of chemokine CXCL10 in dendritic-cell-like S100beta-positive cells in rat anterior pituitary gland","volume":"357","author":"Horiguchi","year":"2014","journal-title":"Cell Tissue Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1677\/JOE-08-0250","article-title":"Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation","volume":"199","author":"Lee","year":"2008","journal-title":"J Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.yfrne.2010.07.001","article-title":"Chemokines and chemokine receptors: new actors in neuroendocrine regulations","volume":"32","author":"Rostene","year":"2011","journal-title":"Front Neuroendocrinol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1158\/1078-0432.CCR-07-4717","article-title":"Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine\/paracrine cell proliferation in human pituitary adenomas","volume":"14","author":"Barbieri","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"592","DOI":"10.3967\/0895-3988.2013.07.011","article-title":"Study on the expression levels of CXCR4, CXCL12, CD44, and CD147 and their potential correlation with invasive behaviors of pituitary adenomas","volume":"26","author":"Xing","year":"2013","journal-title":"Biomed Environ Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2826.2009.01867.x","article-title":"Signalling pathway mediated by CXCR7, an alternative chemokine receptor for stromal-cell derived factor-1alpha, in AtT20 mouse adrenocorticotrophic hormone-secreting pituitary adenoma cells","volume":"21","author":"Yoshida","year":"2009","journal-title":"J Neuroendocrinol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.2741\/1755","article-title":"The RAS\/RAF\/MEK\/ERK and PI3K\/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma","volume":"10","author":"Meier","year":"2005","journal-title":"Front Biosci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1677\/ERC-09-0101","article-title":"Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors","volume":"16","author":"Dworakowska","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejca.2011.11.002","article-title":"Targeting Raf\/MEK\/ERK pathway in pituitary adenomas","volume":"48","author":"Suojun","year":"2012","journal-title":"Eur J Cancer"},{"key":"B50","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-012-9682-3","article-title":"PI3K\/Akt\/mTOR and Raf\/MEK\/ERK signaling pathways perturbations in non-functioning pituitary adenomas","volume":"42","author":"Rubinfeld","year":"2012","journal-title":"Endocrine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1530\/ERC-15-0042","article-title":"Autophagy in endocrine tumors","volume":"22","author":"Weckman","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"B52","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1530\/JME-13-0241","article-title":"Autophagy in the endocrine glands","volume":"52","author":"Weckman","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1475-2867-6-4","article-title":"Cancer: looking for simplicity and finding complexity","volume":"6","author":"Grizzi","year":"2006","journal-title":"Cancer Cell Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1742-4682-3-37","article-title":"Cancer initiation and progression: an unsimplifiable complexity","volume":"3","author":"Grizzi","year":"2006","journal-title":"Theor Biol Med Model"},{"key":"B55","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/nrg3904","article-title":"Cancer genetics: omics analyses of tumour immunity","volume":"16","author":"Burgess","year":"2015","journal-title":"Nat Rev Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1007\/s12035-013-8593-5","article-title":"Systematic review of protein biomarkers of invasive behavior in glioblastoma","volume":"49","author":"Sayegh","year":"2014","journal-title":"Mol Neurobiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T17:36:32Z","timestamp":1653154592000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fendo.2015.00141\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,11]]},"references-count":56,"URL":"https:\/\/doi.org\/10.3389\/fendo.2015.00141","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,11]]}}}